THE CHROMOSOME 18 CLINICAL RESEARCH CENTER

18 号染色体临床研究中心

• 批准号: 7627530
• 负责人: JANNINE De Mars CODY
• 金额: $ 14.75万
• 依托单位: UNIVERSITY OF TEXAS HLTH SCIENCE CENTER
• 依托单位国家: 美国
• 财政年份: 2007
• 资助国家: 美国
• 起止时间: 2007-04-01 至 2008-03-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7627530
• 关键词: Affect; Age; Aneuploidy; Basic Science; Behavioral; Brain; Child; Chromosomal Duplication; Chromosome abnormality; Chromosomes; Chromosomes, Human, Pair 18; Clinical; Clinical Data; Clinical Research; Cognitive; Computer Retrieval of Information on Scientific Projects Database; Congenital chromosomal disease; Corticotropin; Data; Dental; Diploidy; Disease; Dysmorphology; Ear; Evaluation; Family; Funding; Genes; Genotype; Goals; Gonadal Steroid Hormones; Grant; Individual; Institution; International; Magnetic Resonance Imaging; Measurement; Medical; Mental Retardation; Molecular; Neurology; Nose; Numbers; Parents; Participant; Pharyngeal structure; Phenotype; Range; Research; Research Personnel; Resources; Somatotropin; Source; Speech Pathology; Syndrome; Testing; Thyroid Gland; Time; United States National Institutes of Health; Visit; growth hormone deficiency; insight; pediatric department

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. OBJECTIVE: Aneusomy syndromes are chromosomal disorders resulting from loss or duplications of chromosomal regions. There are two opposing views about how aneusomy causes disease. One view strongly supports the notion that a chromosomal imbalance, regardless of which region is unbalanced, is sufficient to explain many of the phenotypic features seen in aneusomy syndromes. Since the majority of aneusomy syndromes result in broad features such as mental retardation, experts argue that single gene correlations with these phenotypes is highly unlikely. The other view argues that by analyzing a wide variety of syndromes, it can be demonstrated that different aneuploid phenotypes are specific and distinguishable from one another. From this information it has been inferred that aneuploid phenotypes are determined by specific genes encoded in the region of imbalance. In San Antonio, we are systematically studying children with chromosome 18 aneusomies to test the following hypotheses: 1. Growth hormone deficiency in children with chromosome 18 deletions is accompanied by cognitive and microstructural abnormalities of the brain that can be ameliorated by GH therapy. 2. The physical and behavioral findings in individuals with the abnormalities of chromosome 18 are due to the genes that are present on a non-diploid number. Therefore, correlation of the physical and behavioral findings with the extent of their deletion will help to identify the genes involved. An understanding of the molecular mechanisms of these findings will provide the insight necessary to devise appropriate therapy. METHODS: The UTHSCSA Department of Pediatrics established the Chromosome 18 Clinical Research Center with the following three goals: 1. To be the international medical and educational resource for the families of individuals with chromosome 18 abnormalities. 2. To perform and facilitate both clinical and basic research relating to the syndromes of chromosome 18. 3. To devise treatments to help these individuals overcome the effects of their chromosome abnormality. In order to attain these goals, extensive data must to be gathered on both the phenotype and genotype of these individuals: We therefore propose the following specific aims: 1. Perform a genotypic analysis to determine: A. The genotype of the affected individual B. The parent of origin of the chromosome with the abnormality 2. Gather comprehensive clinical data on individuals with chromosome 18 abnormalities including: A. Determination of growth hormone status. B. Measurement of corticotropin, thyroid and sex hormone levels C. Behavioral and neuropsychometric evaluations D. Audiological and ear, nose and throat examination E. Magnetic resonance imaging (MRI) of the brain F. Dysmorphology evaluation G. Neurology examination H. Dental evaluation I. Speech Pathology evaluation J. Psychiatric evaluation The phenotypic assessment will be longitudinal; therefore the participants will have a wide age range. This wide age range as well as the fact that some participants may be assessed multiple times means that every component of our assessment may not be appropriate for every participant at every visit.

该子项目是利用该技术的众多研究子项目之一 资源由 NIH/NCRR 资助的中心拨款提供。子项目和 研究者 (PI) 可能已从 NIH 的另一个来源获得主要资金， 因此可以在其他 CRISP 条目中表示。列出的机构是 对于中心来说，它不一定是研究者的机构。 目的：染色体异常综合征是由染色体区域丢失或重复引起的染色体疾病。 关于异形如何导致疾病存在两种相反的观点。 一种观点强烈支持这样一种观点，即染色体不平衡，无论哪个区域不平衡，都足以解释在畸形综合征中看到的许多表型特征。 由于大多数畸形综合征都会导致智力低下等广泛特征，因此专家认为单基因与这些表型相关的可能性极小。 另一种观点认为，通过分析多种综合征，可以证明不同的非整倍体表型是特定的并且可以彼此区分。 从该信息推断，非整倍体表型是由不平衡区域编码的特定基因决定的。 在圣安东尼奥，我们正在系统地研究 18 号染色体异常的儿童，以检验以下假设： 1. 18 号染色体缺失儿童的生长激素缺乏症伴有大脑认知和微结构异常，可通过 GH 治疗改善。 2. 18 号染色体异常个体的身体和行为表现是由于非二倍体上存在的基因造成的。因此，将身体和行为发现与其缺失程度相关联将有助于识别所涉及的基因。了解这些发现的分子机制将为设计适当的治疗提供必要的见解。 方法：UTHSCSA 儿科建立 18 号染色体临床研究中心的目标如下： 1. 成为 18 号染色体异常患者家庭的国际医疗和教育资源。 2. 开展和促进与18号染色体综合征相关的临床和基础研究。 3. 设计治疗方法来帮助这些个体克服染色体异常的影响。 为了实现这些目标，必须收集有关这些个体的表型和基因型的大量数据：因此，我们提出以下具体目标： 1. 进行基因型分析以确定： A. 受影响个体的基因型 B. 异常染色体的亲本 2. 收集 18 号染色体异常个体的全面临床数据，包括： A. 生长激素状态的测定。 B. 促肾上腺皮质激素、甲状腺和性激素水平的测量 C. 行为和神经心理测量评估 D.听力学和耳鼻喉检查 E. 大脑磁共振成像 (MRI) F. 形态异常评估 G. 神经内科检查 H. 牙科评估 一、言语病理学评估 J. 精神病学评估 表型评估将是纵向的；因此，参与者的年龄范围很广。这种广泛的年龄范围以及某些参与者可能会接受多次评估的事实意味着我们评估的每个组成部分可能并不适合每次访问的每个参与者。